HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiBiO Therapeutics aspires to benefit patients through open-innovation partnerships with industry and academia. 

Biotechnology

HiFiBiO

HiFiBiO's headquarters in Cambridge, MA, United States

Liang Schweizer

Francisco Adrian

Steven Chen

Leslie Kean

Michael Croft

Sebastian Amigorena

Aurélien Marabelle

Andrew Griffiths

Robert Nicol

Jérôme Bibette

Bradley Bernstein

Dave Weitz

Giovanni Abbadessa

Peter Ho

Wendye Robbins

The Research and Development team at HiFiBiO Therapeutics focuses on leveraging advanced single-cell profiling technologies to drive the discovery and development of innovative antibody drugs aimed at treating cancer and autoimmune disorders. Comprising a diverse group of experts, including scientists and clinical operations professionals, the team collaborates closely with external partners to enhance therapeutic strategies and accelerate the transition from laboratory research to clinical applications.

Research and Development

The Leadership Team at HiFiBiO Therapeutics is responsible for guiding the strategic vision and direction of the company. Comprised of the founders and key scientific leaders, this team drives the integration of innovative research and advanced biotherapeutics development, while fostering collaborations with industry and academic partners to enhance the company’s capabilities in mobilizing the human immune system to tackle cancer and autoimmune diseases. Their collective expertise ensures that HiFiBiO remains at the forefront of therapeutic advancements and patient care.

Leadership Team

The Scientific Research Team at HiFiBiO Therapeutics drives the discovery and development of innovative biotherapeutics by leveraging advanced single-cell profiling technologies and in-depth biological expertise. Comprising leaders in various scientific fields, the team collaborates on identifying promising antibody candidates, conducting preclinical studies, and translating research findings into effective treatments for cancer and autoimmune disorders, all while fostering open-innovation partnerships to enhance therapeutic outcomes.

Scientific Research Team

HiFiBiO

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Scientific Research Team

Offices

HiFiBiO

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Scientific Research Team

Offices

Related companies